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Supplementary Figure 1  
 
Gating strategy for F4/80+CD206+ M2-like macrophages in adipose tissue  
Representative flow cytometry analysis of the eWAT.  Cells in the SVF of eWAT from C57BL/6 
mice were analyzed using flow cytometry. Cells were isolated from enzymatically digested 
mouse eWAT. After the exclusion of doublets and debris, dead cells were excluded by 7AAD 
staining. Leukocytes in SVF were identified by CD45 staining. To identify F4/80 and CD206 
expression, CD45+ cells were stained with isotype control antibodies for anti-F4/80 and anti-
CD206 antibodies 
a 
Supplementary Figure 2 
b 
c d 
e 
CD206 
Tissue specific enhancer/ 
promoter 
DT-receptor DNA 
Targeted cell 
(CD206 cell) 
DTR CD206DTR cells 
+ DT  
WT CD206DTR 
257 bp (DTR  primer 1,3) 
138 bp (WT primer 1,2) 
Merge with Nuclei DTR CD206 
W
T
 
C
D
2
0
6
D
T
R
 
WT 
CD206DTR 
0
5
10
15
20
25
30
6 7 8 9 10 11 12 13 14
B
o
d
y
 w
e
ig
h
t 
 (
g
) 
Weeks 
β-Actin 
DTR 
WT CD206DTR 
eWAT MW 
←~27kDa 
←42kDa 
Supplementary Figure 2 
Creation of CD206DTR mice 
(a) Schematic representation of creation CD206DTR mice. Depletion of CD206 M2-like 
macrophages by DT administration. (b) PCR-genotyping analysis showing a 257-bp specific 
DTR sequence in CD206DTR mice. (c) Confocal immunofluorescence double staining of 
DTR and CD206 in eWAT. The images were taken by using confocal miscroscope Leica 
TCS-SP5, 63x oil, scale bar, 25 mm. (d) Western blot analysis showing DTR protein levels 
in the eWAT of CD206DTR mice. (e) Body weight changes of CD206DTR mice and WT 
littermates (n=3-5 mice per group). The data are shown as the means ± SEM.  *P < 0.05 
compared with littermates by Student's t-test.  
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Supplementary Figure 3 
Gating strategy for M1- and M2-like macrophages 
Cells were isolated from enzymatically digested C57BL/6 (or WT) mouse eWAT. After the 
exclusion of doublets and debris, dead cells (7AAD+ cells) were excluded by 7AAD 
staining. Leukocytes in SVF were identified by CD45 staining. CD45+ cells were further 
gated for F4/80-positive macrophages. To identify M1 and M2 macrophages, 
CD45+F4/80+cells were stained for CD11c and CD206 respectively. 
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Supplementary Figure 4 
Gene expression analysis of WAT and BM 
(a) The relative mRNA expression of various hematopoitic cell marker genes in the eWAT. (b) 
The relative mRNA expression of fibrosis related marker genes in eWAT. (c) Representative 
images of Azan-stained sections of eWAT from DT-treated WT and CD206DTR mice. Scale 
bars, 500 μm. Fibrotic area (blue) was analyzed by ImageJ software. Data are representative of 
at least two independent experiments. (d) The relative mRNA expression of M1-like and M2-
like macrophages markers in the iWAT. (e, f) The relative mRNA expression of M1/M2 
macrophage markers in the BM and liver and skeletal muscle after DT treatment (n=5-6 mice 
per group). The data are shown as the means ± SEM.  *P < 0.05 compared with littermates by 
Student's t-test.  
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Flow cytometry analysis of Peritoneal cavity macrophages and BM 
(a) Representative flow cytometry analysis of peritoneal cavity macrophages from WT mice 
(upper panel) and M1- and M2-like macrophage quantification in WT and CD206DTR mice 
(lower panel). After the exclusion of doublets and debris, dead cells were excluded by 7AAD 
staining. Leukocytes in peritoneal cavity were identified by CD45 staining. CD45+ cells were 
further gated for F4/80-positive macrophages to identify M1 and M2 macrophages. Isotype 
control antibody for the anti-CD11c and anti-CD206 were used as a negative control. The data 
are shown as the means ± SEM.  *P < 0.05 compared with littermates by Student's t-test.  
(b) The relative mRNA expression of granulocytes, natural killer cells and eosinophils in BM 
from DT-treated WT and CD206DTR mice. The data are shown as the means ± SEM.  *P < 
0.05 compared with littermate by Student's t-test. (c) Representative flow cytometry analysis 
of eosinophils (SiglecF+) in BM from WT and CD206DTR mice (left panel) and quantification 
of these cells (right panel). Live (7AAD-) cells were gated for CD45+ cells and then SiglecF 
fraction was analyzed in CD45+ cells. Isotype control antibody was used as a negative control. 
The data are shown as the means ± SEM.  *P < 0.05 compared with littermates by Student's t-
test.  
(d) Representative flow cytometry analysis of CD11b and Gr-1 expression in BM (left panel) 
and quantification of CD11hi Gr-1hi and CD11bint Gr-1int cells (right panel). Live (7AAD-) cells 
were gated for CD45+ cells and then CD11b and Gr-1 expression was analyzed in CD45+ cells. 
Isotype control antibody for the relative antibodies were used as a negative control. The data 
are shown as the means ± SEM.  *P < 0.05 compared with littermate by Student's t-test. (e) 
BrdU gating; Live SVF cells (7AAD- cells) from WT mice were gated for CD45+ and CD45- 
population. Then BrdU was analyzed in both fraction including CD45+ BrdU+ and CD45- 
BrdU+ population. Isotype control antibody for the anti-BrdU was used as a negative control. 
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Schematic diagram of MACS study and co-localization of CD206 with PDGFRa 
(a) A schematic diagram showing the MACS processing. First, the eWAT was fractionated into 
adipocytes and SVF. The SVF were then processed MACS bead, as described in the 
methodology section. (b) The flow cytometry detection of the APs in SVF from WT mice 
First, negative selection of CD31+ (endothelial), FITC-lineage cocktail cells were selected 
followed by positive selection of PDGFRa+ and Sca-1+ cells (APs). Isotype of antibodies were 
used as negative control. This experiment was performed with a FACSDiva Version 6.1.2 
automated cell analyzer (Becton Dickinson FACSCanto II) and cell sorting was performed by 
an automatic cell sorting analyzer (Becton Dickinson FACSAria SORP). (c) High resolution 
confocal imaging of frozen eWAT sections from PDGFRa-CreERT2-Egfp (PRa) mice stained 
for CD206 vs GFP. These pictures were taken by using Leica TCS-SP5 (Magnification 63x) 
oil. Scale bar, 25 mm. (d) Confocal immunofluoresence staining of CD206 co-localized with 
PDGFRa. These pictures were taken by using LSM780 (Magnification 40x). Scale bar, 25 mm. 
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(a) A schematic diagram showing creation of CD206-CreERT2/TGFbflox/flox mice. (b) Relative 
mRNA expression of FACS-sorted CD206+ cells from the eWAT of tamoxifen treated CD206-
CreERT2/TGFbflox/flox mice compared with control TGFbflox/flox mice (n=3). The data are shown as 
the means ± SEM.  *P < 0.05 compared with littermate by Student's t-test.  (c) Relative mRNA 
expression of eWAT and SVF from the eWAT of CD206-CreERT2/TGFbflox/flox mice compared 
with control TGFbflox/flox mice (n=4-5).  The data are shown as the means ± SEM.  *P < 0.05 
compared with littermates by Student's t-test.  
(d) The flow cytometry detection of the APs in SVF from WT mice. First, negative selections of 
CD31+ (endothelial), FITC-lineage cocktail cells were selected followed by positive selection of 
PDGFRa+ and Sca-1+ cells. This experiment was performed with a FACSDiva Version 6.1.2 
automated cell analyzer (Becton Dickinson FACSCanto II) and cell sorting was performed by an 
automatic cell sorting analyzer (Becton Dickinson FACSAria SORP).  
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Creation of CD206-CreERT2/TGFbflox/flox mice 
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Supplementary Figure 8  
Fibrosis of eWAT 
Representative images of Azan-stained sections of eWAT from mice used tamoxifen treated 
CD206-CreERT2/TGFb1flox/flox mice compared to tamoxifen treated TGFb1flox/flox control mice. 
Scale bars, 500 μm. Fibrotic area (blue) was analyzed by ImageJ software. The data are shown as 
the means ± SEM.  *P < 0.05 compared with littermates by Student's t-test. Data are 
representative of at least two independent experiments. 
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Supplementary Fig. 9 
IL-4-induced BMDM expression of CD206 and TGFβ1  
(a) Representative flow cytometry analysis of BMDMs cultured with IL-4 (10 ng/mL, final 
concentration) and PGE2 (50 ng/mL, final concentration) for 24 hours. (b) Immunostaining of 
CD206 and TGFβ1. Scale bar, 100mm (c) Relative mRNA expression of CD206 (upper panel) 
and TGFβ1 (lower panel). The data were calculated from experiments with 3-6 dishes per group. 
The data are shown as the means ± SEM.  *P < 0.05, **P < 0.01 (ANOVAs with the post Tukey-
Kramer test and Bonferroni correction).  
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Supplementary Fig. 10   
IP-GTT in NC-fed mice and generation of smaller  adipocytes 
(a) The glucose concentrations in an intra-peritoneal glucose tolerance test (IP-GTT) in NC-fed 
CD206DTR and WT mice without DT treatment (n=3-5 per group). (b) Uncropped scan of 
western blot of liver from DT-treated WT and CD206DTR mice. (c) Representative HE-
immunohistochemistry micrographs (left panel) and adipocyte size and cell count 
measurements (right panel) in the eWAT of CD206-CreERT2/TGFbflox/flox compared with 
TGFbflox/flox control mice are shown. (200x magnifications); Red scale: 200 μm. (n=3 per 
group). The data are shown as the means ± SEM.  *P < 0.05 compared with littermates by 
Student's t-test.  
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Supplementary Figure 11 
HFD mice food intake, body weight, and histogram of the eWAT 
(a) Food intake before and after DT-treated HFD-fed CD206DTR and WT mice. (b) Body 
weights of the WT and CD206DTR mice during 16 weeks of HFD (n=4-6 mice per group). (c) 
Body weights before and after DT administration in the HFD-fed CD206DTR and WT mice 
(n=4-6 mice per group). The data are shown as the means ± SEM.  *P < 0.05 compared with 
littermates by Student's t-test.  
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Supplementary Figure 12   
Gating strategy for M1- and M2-like macrophages and APs  
(a) Gating strategy for M1 and M2 macrophages in SVF. CD45+ F4/80+ CD11c+ population 
was selected for M1-like while CD45+ F4/80+ CD206+ population was analyzed for M2-like 
macrophages. FMO of CD206 and CD11c was used to justify the gating. Isotype control 
antibodies for anti-CD11c and anti- CD206 antibodies were used as negative controls. (b) 
Representative images of flow cytometry detection of the APs in the eWAT. First, negative 
selection of CD31+ (endothelial), FITC Lineage cocktail cells was selected followed by 
positive selection of PDGFRa+ and Sca-1+ cells. These experiments were performed with a 
FACSDiva Version 6.1.2 automated cell analyzer (Becton Dickinson FACSCanto II).  
Ki-67 Forward: CGCCAACCAAGAGGAAGTCT                             Reverse: GGGGCCGTTCCTTGATGATT 
p15 Forward: CCACCCTTACCAGACCTGTG Reverse: AGGCGTCACACACATCCAG 
p16 Forward: GAACTCTTTCGGTCGTACCC Reverse: CGAATCTGCACCGTAGTTGA 
p21 Forward: GACATCTCAGGGCCGAAAAC Reverse: CGGCGCTTGGAGTGATAGAA 
p27 Forward: AGGAGAGCCAGGATGTCAGC Reverse: CAGAGTTTGCCTGAGACCCAA  
p57 Forward: GGAGCAGGACGAGAATCAAG Reverse: GAAGAAGTCGTTCGCATTGG 
TGFβ1 Forward: AAGTTGGCATGGTAGCCCTT Reverse: GCCCTGGATACCAACTATTGC 
TGFβ2 Forward: AGGAGGTTTATAAAATCGACATGC  Reverse: TAGAAAGTGGGCGGGATG 
TGFβ3 Forward: CCCTGGACACCAATTACTGC  Reverse: TCAATATAAAGGGGGCGTACA 
C/EBPα Forward: TGGACAAGAACAGCAACGAG Reverse: TCACTGGTCAACTCCAGCAC 
CD24 Forward: TGCTCCTACCCACGCAGATT Reverse: GCGTTACTTGGATTTGGGGAAGCA 
Pref-1 Forward: AACCATGGCAGTGCATCTG Reverse: GCATTCGTACTGGCCTTTCT 
Zbtb46 Forward: AGAGAGCACATGAAGCGACA                                                 Reverse:  CTGGCTGCAGACATGAACAC 
Sca1 Forward: TCTGAGGATGGACACTTCTC                                                   Reverse: CTCAGGCTGAACAGAAGCAC  
Supplementary Table 1   
The sequences of SYBR Green primers  used for RT PCR 
